New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 21, 2014
07:04 EDTCASICASI Pharmaceuticals' receives approval from CFDA to conduct clinical trial
CASI Pharmaceuticals announced that China's Food and Drug Administration, or CFDA has approved the Company's application to conduct a Phase II clinical trial in triple-negative breast cancer patients in China for its proprietary drug candidate, ENMD-2076.
News For CASI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 26, 2014
17:10 EDTCASISpectrum reports 16.66% stake in CASI Pharmaceuticals
Spectrum entered into the investment agreements in order to acquire shares of common stock of CASI Pharmaceuticals for investment purposes with the goal of increasing the value of the company as a result of, among other things, CASI's development and commercialization of Zevalin and captisol-enabled melphalan in Greater China.
September 18, 2014
07:07 EDTCASISpectrum out-licenses rights for Greater China to CASI for three drugs
Subscribe for More Information
07:05 EDTCASISpectrum out-licenses rights for Greater China to CASI for three drugs
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use